HONG KONG, Aug. 6, 2024 /PRNewswire/ — Recently, Hurricane Beryl, a Category 4 storm, wreaked havoc in the southeastern Caribbean, bringing intense winds and heavy rainfall that resulted in at least six fatalities and severe damage in many areas. In the Cumanacoa region of Venezuela, torrential rains caused rivers to overflow, damaging numerous vehicles and collapsing […]
Category Archives: Pr Newswire
Samsung Biologics to embed PSCI principles into business practices for responsible value chain management Supplier Partnership reaffirms company’s commitment to decarbonize and build resilient supply chains INCHEON, South Korea, Aug. 6, 2024 /PRNewswire/ — Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), announced today that the company has joined the Pharmaceutical Supply […]
HONG KONG, Aug. 6, 2024 /PRNewswire/ — Even with the ever-changing situation, technological innovation is still the most critical component for biopharmaceutical companies’ long-term development. This continuous innovation keeps companies up to date and promotes the evolution of R&D and the success of commercialization. Recently, Viva Biotech’s portfolio companies have new updates. Keep reading for […]
NEW YORK, Aug. 6, 2024 /PRNewswire/ — Aquaron Acquisition Corp. (NASDAQ: AQU, the “Company“), a special purpose acquisition company, announced today that HUTURE Ltd. (“Huture“) has deposited into the Company’s trust account (the “Trust Account“) an aggregate of $20,000, in order to extend the period of time the Company has to complete a business combination […]
Chief Executive Jonathan Gear to Step Down as CEO and Member of the Board LONDON, Aug. 6, 2024 /PRNewswire/ — Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced that the Board has appointed Matti Shem Tov, former CEO of ProQuest, as the Company’s next CEO, effective August 9, 2024. Mr. […]
Pr Newswire
Belite Bio to Host Webcast on August 12, 2024, to Discuss Second Quarter 2024 Financial Results
06
Aug
Aug
SAN DIEGO, Aug. 05, 2024 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that it will host a webcast on Monday, August 12, 2024, at 4:30 p.m. Eastern Time to discuss the […]
Pr Newswire
ONWARD® Medical Reaffirms 2024 Strategic Priorities and Releases Unaudited Q2 Financial Highlights
06
Aug
Aug
Company expects to commercialize the investigational ARC-EX® System in Q4 2024 and has commenced launch preparations Company preparing to initiate global pivotal trial for investigational ARC-IM® Therapy to address blood pressure instability after spinal cord injury Company expects to advance clinical and development activities for its unique ARC-BCI™ brain-computer interface therapy EINDHOVEN, the Netherlands, Aug. […]
06
Aug
Aug
MALVERN, Pa., Aug. 05, 2024 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced the granting of inducement awards of Restricted Stock Units representing a total of 55,200 shares […]
Pr Newswire
Vision Sensing Acquisition Corp. Announces Payment of Fee to Extend Period to Consummate Initial Business Combination to September 3, 2024
06
Aug
Aug
New York, Aug. 05, 2024 (GLOBE NEWSWIRE) — Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW) (the “Company”) a special purpose acquisition company, announced today that on August 2, 2024, its sponsor, Vision Sensing, LLC, deposited $51,016.10 into the Company’s trust account, which is the sum that the Company must pay to extend the date […]
SHANGHAI, Aug. 6, 2024 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that it will report its interim results for the six months ended June 30, 2024, and provide a business update on August 28, 2024. […]